Cardiovascular Systems (CSII) Stock Price, News & Analysis

Cardiovascular Systems, Inc. (NASDAQ:CSII) announced its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company had revenue of $61.45 million for the quarter, compared to analysts' expectations of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. The business's quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the company posted ($0.23) earnings per share.

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).